D-0231-2022 Class II Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0231-2022 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Oct 25, 2021 and is designated Class II. Reason for recall: Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product. The recall status is terminated (terminated Sep 1, 2022). Affected quantity: 36,786 30-count bottles.

Recall details

Product Type
Drugs
Report Date
Nov 17, 2021
Initiation Date
Oct 25, 2021
Termination Date
Sep 1, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
36,786 30-count bottles

Product description

Tadalafil Tablets, USP 20 mg, 30 count bottle, Rx Only, Manufactured for: Northstar Rx LLC Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited, India, NDC # 16714-077-01

Reason for recall

Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.

Distribution pattern

Distributed to one distributor who may have further distribute the product nationwide.

Code information

Lot # DNC0814A, DNC0815A, Exp. Date 04/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0231-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0231-2022. Report a data issue: hello@regdatalab.com.